Personalised cancer vaccine takes step closer to market | India News
NEW DELHI: A personalised cancer vaccine has shown encouraging results in a large Phase-3 trial of patients with high-risk melanoma – a potentially aggressive form of skin cancer – helping keep the cancer from returning or spreading when given along with Merck’s immunotherapy Keytruda, pharma major Moderna said in a statement. Keytruda helps the body’s…
